acute myeloid leukemia (AML) | Page 3 | Aplastic Anemia & MDS International Foundation Return to top.

acute myeloid leukemia (AML)

Medicare Made Simple for Patients

Program participants will learn the basics of Medicare including how and when to enroll, the different parts of Medicare, the difference between Advantage and Supplement plans and what original Medicare does not cover, eligibility, how to avoid penalties, when to qualify for disability after a blood cancer diagnosis and which part covers infusion versus which part covers pill medications.

Areej El-Jawahri, MD

El-Jawahri, Areej
Associate Director, Cancer Outcomes Research and Education Program
Massachusetts General Hospital

Dr. El-Jawahri is an oncologist specializing in the care of patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation. Clinically, she takes care of patients with acute leukemia, myelodysplastic syndrome, chronic leukemias, lymphomas, and myelomas.

Aplastic Anemia, MDS, and PNH Virtual Support Group - 2022 September

Event Date: 
Sat, 09/24/2022 - 10:30am (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Press Release Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review

BOSTON--(BUSINESS WIRE)--Aug. 1, 2022-- Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious diseases, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment of patients with blood cancers in need of an allogenic hematopoietic stem cell transplant.

Aplastic Anemia, MDS, and PNH Virtual Support Group - 2022 August

Event Date: 
Sat, 08/27/2022 - 10:30am (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Share with addtoany.com.